USAID/Tanzania Malaria Surveillance and Monitoring (TMSM) | RFI 621 17 00001

Opportunity Information: Apply for RFI 621 17 00001

The USAID/Tanzania Malaria Surveillance and Monitoring (TMSM) opportunity is a USAID-funded cooperative agreement designed to strengthen how Tanzania tracks, understands, and responds to malaria. Its central goal is to support the Government of Tanzania in reducing malaria illness and deaths now, while also building the surveillance and monitoring capacity needed to move toward the longer-term objective of malaria elimination. Rather than focusing only on delivering commodities or clinical services, the award emphasizes generating and using high-quality data so that national and local partners can make faster, more targeted, and more effective program decisions.

The activity concentrates on four closely related technical areas. First is malaria surveillance, meaning improved collection, analysis, and use of epidemiological data to identify where cases are rising, where transmission is persisting, and where outbreaks or clusters (foci) may be forming. Second is entomological monitoring, which involves measuring mosquito populations, their behavior, and their role in transmission, with specific attention to insecticide resistance monitoring. This is crucial because resistance can reduce the impact of core vector control tools and can vary by geography. Third is drug efficacy monitoring, also referred to in the description as therapeutic efficacy monitoring, which tracks whether first-line antimalarial treatments are still working as expected. Detecting reduced efficacy early helps protect treatment policies and patient outcomes. Fourth is monitoring of other vector control interventions, including the performance of tools and strategies used to reduce mosquito populations or human-mosquito contact; the description specifically notes that this information will help adjust indoor residual spraying (IRS) and other interventions to fit different transmission profiles across zones.

A major theme in the opportunity is adaptive management based on better evidence. By improving both epidemiological and entomological data, the recipient and government counterparts are expected to refine responses to outbreaks and hotspots and to tailor interventions to local conditions. In practice, that means using surveillance signals to trigger investigations and response, using entomological findings (like insecticide resistance patterns) to select appropriate insecticides or strategies, and using therapeutic efficacy results to inform national treatment guidance. The intent is a tighter feedback loop between data collection and action, so resources are directed where they will have the greatest impact and program changes can be made before problems become widespread.

The target populations named for TMSM are pregnant women and children under five, reflecting groups that face the highest risk of severe disease and death from malaria and are often prioritized in national malaria strategies. While the monitoring systems supported by the award will likely benefit the broader population by improving overall program performance, the stated emphasis is on protecting these vulnerable groups through better-informed prevention and treatment policies and faster detection of changes in transmission, vector behavior, or drug effectiveness.

From an administrative standpoint, this is a discretionary funding opportunity issued by the U.S. Agency for International Development (USAID), Tanzania mission in Dar es Salaam, using a cooperative agreement mechanism. A cooperative agreement typically implies substantial involvement by USAID during implementation, such as collaboration on work planning, technical direction, and monitoring expectations. The opportunity falls under the Health funding activity category and is associated with CFDA number 98.001. Eligibility is listed as unrestricted, meaning a wide range of organizations could apply, subject to any additional eligibility clarifications that may appear in the full notice.

The funding details indicate a single anticipated award (ExpectedAwards: 1) with an award ceiling of USD 12,600,000. The funding opportunity number is RFI 621 17 00001. The notice was created on September 21, 2017, with an original closing date of October 5, 2017. Overall, the opportunity is best understood as an investment in Tanzania's malaria intelligence and response capacity, integrating human case surveillance with vector and drug resistance monitoring so malaria control decisions can be more targeted, timely, and effective.

• The Agency for International Development, Tanzania USAID-Dar es Salaam in the health sector is offering a public funding opportunity titled "USAID/Tanzania Malaria Surveillance and Monitoring (TMSM)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
• This funding opportunity was created on Sep 21, 2017.
• Applicants must submit their applications by Oct 05, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $12,600,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for RFI 621 17 00001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: